Similar articles

• Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.

  Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA. Harper L, et al. Clin Endocrinol (Oxf). 2004 Jun;60(6):671-5. doi: 10.1111/j.1365-2265.2004.02029.x. Clin Endocrinol (Oxf). 2004. PMID: 15163328
• Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?

  Lim AY, Kek PC, Soh AW. Lim AY, et al. Singapore Med J. 2013 Jul;54(7):e133-6. doi: 10.11622/smedj.2013145. Singapore Med J. 2013. PMID: 23900475
• Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.

  Žarković M, Wiersinga W, Perros P, Bartalena L, Donati S, Okosieme O, Morris D, Fichter N, Lareida J, Daumerie C, Burlacu MC, Kahaly GJ, Pitz S, Beleslin B, Ćirić J, Ayvaz G, Konuk O, Törüner FB, Salvi M, Covelli D, Curro N, Hegedüs L, Brix T; EUGOGO (European Group on Graves’ Orbitopathy). Žarković M, et al. J Endocrinol Invest. 2021 Feb;44(2):371-378. doi: 10.1007/s40618-020-01320-7. Epub 2020 Jun 10. J Endocrinol Invest. 2021. PMID: 32524368
• [An underestimate iatrogenic effect of antithyroid drugs: Acute pancreatitis].

  Ben Hamou A, Banu I, Dupuy O. Ben Hamou A, et al. Presse Med. 2019 Nov;48(11 Pt 1):1334-1336. doi: 10.1016/j.lpm.2019.09.043. Epub 2019 Nov 11. Presse Med. 2019. PMID: 31727489 Review. French. No abstract available.
• Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.

  Bednarczuk T, Schomburg L. Bednarczuk T, et al. Hormones (Athens). 2020 Mar;19(1):31-39. doi: 10.1007/s42000-019-00133-5. Epub 2019 Nov 13. Hormones (Athens). 2020. PMID: 31721133 Free PMC article. Review.